These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clinical diagnosis of MM2-type sporadic Creutzfeldt-Jakob disease. Hamaguchi T, Kitamoto T, Sato T, Mizusawa H, Nakamura Y, Noguchi M, Furukawa Y, Ishida C, Kuji I, Mitani K, Murayama S, Kohriyama T, Katayama S, Yamashita M, Yamamoto T, Udaka F, Kawakami A, Ihara Y, Nishinaka T, Kuroda S, Suzuki N, Shiga Y, Arai H, Maruyama M, Yamada M. Neurology; 2005 Feb 22; 64(4):643-8. PubMed ID: 15728285 [Abstract] [Full Text] [Related]
7. Glucose metabolism in sporadic Creutzfeldt-Jakob disease: a statistical parametric mapping analysis of (18) F-FDG PET. Kim EJ, Cho SS, Jeong BH, Kim YS, Seo SW, Na DL, Geschwind MD, Jeong Y. Eur J Neurol; 2012 Mar 22; 19(3):488-93. PubMed ID: 22050286 [Abstract] [Full Text] [Related]
9. Comparison of diffusion-weighted MRI and 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) for detecting primary colorectal cancer and regional lymph node metastases. Ono K, Ochiai R, Yoshida T, Kitagawa M, Omagari J, Kobayashi H, Yamashita Y. J Magn Reson Imaging; 2009 Feb 22; 29(2):336-40. PubMed ID: 19161185 [Abstract] [Full Text] [Related]
10. A correlative study of FDG PET, MRI/CT, electroencephalography, and clinical features in subacute sclerosing panencephalitis. Yilmaz K, Yilmaz M, Mete A, Celen Z. Clin Nucl Med; 2010 Sep 22; 35(9):675-81. PubMed ID: 20706040 [Abstract] [Full Text] [Related]
11. Imaging the early response to chemotherapy in advanced lung cancer with diffusion-weighted magnetic resonance imaging compared to fluorine-18 fluorodeoxyglucose positron emission tomography and computed tomography. Tsuchida T, Morikawa M, Demura Y, Umeda Y, Okazawa H, Kimura H. J Magn Reson Imaging; 2013 Jul 22; 38(1):80-8. PubMed ID: 23239463 [Abstract] [Full Text] [Related]